Study estimates among non-circumcised men were at least twice those among circumcised men. Low-income country estimates were more heterogeneous than high-income country estimates, which indicates poorer study quality, greater heterogeneity of risk factors, or under-reporting of high-risk behaviour. Eff orts are needed to better understand these diff erences and to quantify infectivity in low-income countries.
Introduction
Since the beginning of the HIV epidemic, mother-tochild transmission and iatrogenic transmission through contaminated blood products and unsafe injections have decreased because of improved health procedures and treatment options, particularly in high-income countries. [1] [2] [3] [4] [5] However, the notion that diff erent patterns of sexual behaviours and/or biological factors such as male circumcision and genital ulcer disease (GUD) can explain worldwide diff erences in heterosexual epidemic size has been questioned. [6] [7] [8] [9] Some believe that sexual transmission has been overestimated, whereas iatrogenic transmission has been underestimated. [10] [11] [12] Quantifi cation of the risk of HIV infection after sexual intercourse with an infected partner is needed to better understand the epidemiology of HIV infection worldwide and to enable appropriate public-health decisions to be taken.
Sexual transmission estimates fall broadly into two categories: per-act transmission probabilities, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] which quantify the risk of infection per sexual contact, and perpartner transmission probabilities, 13, [24] [25] [26] [27] which measure the cumulative risk of infection over many sex acts during a partnership. In both cases, transmission probabilities depend on the infectiousness of the HIV-infected partner and the susceptibility of the HIV-uninfected partner. Infectiousness and susceptibility depend on behavioural, biological, genetic, and immunological risk factors of the host and the virus. 5, 6, [21] [22] [23] [24] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] Per-act transmission probabilities are methodologically diffi cult to measure. 43 The time of seroconversion of the index case and the transmission to his or her partner, the number of unprotected sex acts, duration of exposure to HIV, and potential HIV cofactors among the index cases and the susceptible partners at the time of transmission are rarely known precisely, especially for time-varying cofactors, such as recurrent sexually transmitted infections (STIs). 5, 16, [43] [44] [45] Early narrative or methodological reviews have reported a limited selection of per-act estimates. [10] [11] [12] 42, [46] [47] [48] More recently, Powers and colleagues 49 published a systematic review of per-act HIV-1 transmission probabilities of 27 studies based on 15 unique study populations. Our systematic review extends this work by including 43 publications based on 25 diff erent study populations. Our objectives were to provide summary estimates of HIV-1 transmission probabilities per heterosexual contact, to do in-depth univariate and multivariate metaregression analyses to explore the variation across study estimates, and to estimate the infl uence of key risk factors on infectivity. The review focuses on HIV-1, which is more pathogenic and prevalent than HIV-2.
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Methods
Search strategy
The literature search (up to Sept 6, 2008 ) was done in three stages. First, PubMed, Science Direct, and NLM Gateway online databases were searched to September, 2006 , by use of the following search terms: "HIV transmission probability" OR "HIV transmission probabilities" OR "HIV infectivity" OR "HIV infectiousness" NOT "perinatal" NOT "mother to child" NOT "mother-to-child", and by replacing "HIV" by the terms "LAV", "HTLV-III" and "HTLV III". PubMed was searched by titles. Science Direct and NLM Gateway were searched by abstracts, titles, keywords, and authors. The PubMed search was updated twice (to June 29, 2007 , and Review again to Sept 6, 2008 ) by use of more effi cient search terms and Boolean operators, for matches under any fi eld: (HIV OR LAV OR HTLV III OR HTLV-III OR AIDS OR human immunodefi ciency virus OR human T-lymphotropic virus III OR acquired immunodefi ciency) AND (infectiousness OR infectivity OR probability OR contact OR contacts OR partner OR partners OR wives OR spouses OR husbands OR couples OR discordant OR [transmission AND (heterosexual OR homosexual OR risk OR female OR male OR anal)]). Bibliographies of relevant articles were examined for additional references. Four of six authors contacted provided complementary information.
Selection criteria and data extraction
Publications that reported empirical per-act heterosexual HIV-1 transmission probability estimates, or suffi cient information to derive these estimates, were included. Indirect estimates from mathematical modelling studies, reviews, pre-1990 abstracts, and studies with sample sizes fewer than ten were excluded. No other restrictions were put on language, location, study design, or type of exposure. Each publication was examined by two reviewers (RFB, MCB) to extract information on per-act estimates, 95% CIs, and study and participant characteristics, which were used to defi ne covariates. Male-to-female and female-to-male estimates were extracted in preference to combined estimates. Per-act estimates stratifi ed by anal intercourse, genital ulcers, disease stage of the index cases, male circumcision status, and viral load were also extracted.
Meta-analysis
Pooled transmission probability estimates and 95% CI were derived using a random-eff ects model based on the inverse-variance method. [52] [53] [54] Natural log (ln)-transformed study estimates were used to avoid problems associated with heteroscedasticity. 55 To deal with zero values a small value of 0·000001 was used. If not explicitly stated in the publication, per-act transmission probabilities were derived using reports of total or frequency of sexual contacts. To improve consistency across studies, infectivity estimates reported as rates were converted into per-act transmission probabilities (see webappendix for details). 56 Heterogeneity across study estimates was explored by use of the Q statistic, subgroup and sensitivity analyses, and meta-regression techniques. [52] [53] [54] Random-eff ects metaregression models were fi tted on ln-transformed study estimates with the procedure "proc Mixed" in SAS version 9.13. Pooled estimates were exponentiated to obtain estimates on the original scale.
The main meta-analysis was done using the crude sexspecifi c estimates from each publication. If multiple publications reported estimates based on the same study population, the estimate from the largest or most recent sample was included-of these estimates, the largest took precedence. We then did sensitivity analyses by calculating pooled estimates for diff erent subgroups of studies (eg, for women only, with and without commercial-sex exposure [CSE] ). We also used univariate and multivariate meta-regression techniques to explore potential sources of heterogeneity across estimates with the following Figure 1 : Selection of studies on heterosexual per-act HIV-1 transmission probabilities The 43 publications included 26 articles that were included in the main meta-analysis and seven articles only included in the sub-analyses by risk factor. 17, 20, 46, [57] [58] [59] [60] The remaining articles were duplicates and were not included in any analysis, but are shown in webtable 1 for completeness. 62 Covariates were defi ned by available information from each study. The covariate setting was used as a marker of unmeasured risk factors (eg, viral subtype, coinfection). 49 The exposure covariate diff erentiated between studies done among partners after commercial sex, as clients or female sex workers (FSWs), or among partners of index cases infected after blood transfusion, or those exposed to various other sources of HIV (including intravenous drug use or those infected heterosexually). The contamination covariate was defi ned to indicate the likelihood of exposure to HIV via sources (sexual or blood) other than sex with the main index partner. The condom-use covariate characterised studies in which condom use was rare or somewhat controlled for. The STI covariate was defi ned to capture the prevalence of ulcerative STI reported in each study. HIV prevalence from antenatal clinics (ANC) at the time and study location reported from independent sources (eg, WHO's Global Health Atlas) was used as a marker of potential unmeasured parenteral or extramarital exposure, assuming that the risk would increase with HIV prevalence. Further details are provided in the webappendix. Figure 1 shows details of the study selection procedure. Most studies were excluded because they were risk-factor analyses, reported non-sexual or homosexual transmission, per-partner estimates, or did not provide enough information to derive an estimate. 42 studies reporting at least one per-act heterosexual HIV-1 transmission estimate and 13 studies reporting suffi cient information to derive an estimate were identifi ed from the PubMed search and in one case by personal communication. 14 publications, mainly reviews or methodo logical studies, were rejected. 13 additional publications were identifi ed by perusing the bibliographies of relevant articles. 11 publications were rejected based on our pre-defi ned criteria. 43 publications that reported crude per-act estimates or estimates stratifi ed by risk factors were found, [14] [15] [16] [17] [18] [19] [20] [21] based on 25 study populations (webtable 1). 6, [24] [25] [26] [27] [28] 30, 58, 61, 62, 66, [70] [71] [72] 76, 77, 79, 80, 84, [88] [89] [90] [91] [92] [93] Many studies reported results from the same study population (eg, fi ve studies 14, 16, [81] [82] [83] were based on a US Centers for Disease Control and Prevention [CDC] study 25 ) and estimates from the most recent or largest sample were included. Two studies reported on the same study population, 62 ,63 although we assumed them to be independent because they analysed diff erent subpopulations over a diff erent period.
Results
Study selection
Study characteristics
Overall, four study designs were used by the included studies: retrospective partner, prospective discordantcouple, and simple prospective (longitudinal cohort) and retrospective (cross-sectional) studies. In retrospective partner studies, the infection status of each partner becomes known only at the time of the study. The index case and time of infection are determined on the basis of exposure to a salient risk factor. 15, 16, 43, 60, 85 For example, in transfusion studies, the infection time of index cases can be determined more precisely from the date of the transfusion. 16, 25, 27, 43, 76, 79, 80 Otherwise, infection time is estimated by exploring possible dates of infection or by defi ning a distribution of possible infection times by use of information from questionnaires and local epidemic curves or CD4-cell counts. 15, 16, 45, 60, 81, 82, 85 In prospective discordant-couple studies, stable (preferably monogamous) HIV-serodiscordant couples are followed up after diagnosis of the index partner, 19, 20, 70, 72 *Random-eff ects models. †Calculated on the ln scale. ‡Studies that included CSE were removed to assess their infl uence. §Estimates of CSE were all from low-income countries and were the only non-partner studies. To avoid duplication, 26 of 43 studies were included in the main meta-analysis of crude (unstratifi ed by risk factors) estimates (webtable 1). We included male-tofemale and female-to-male estimates were in preference to combined estimateds where possible. All but one 75 of these 26 studies reported on data collected before 2001 from high-income (Europe, North America) or low-income (Africa, Asia, Haiti) country settings. Seven studies from low-income countries were prospective discordant-couple studies, 19, 62, 63, 66, [70] [71] [72] fi ve were simple retrospective or prospective studies, 21, 61, 64, 73, 75 and one was a retrospective partner study. 67 High-income country estimates were all derived from prospective discordant-couple studies 18, 76, 80, 84, [87] [88] [89] or retrospective partner studies. 15, 16, [77] [78] [79] 81, 87 
Study quality
The reported information on study quality and potential sources of biases varied across studies. For example, in retrospective-partner studies, the identifi cation of index cases and time of infection may be more precise if index cases have been infected through contaminated blood products rather than intravenous drug use, or bisexual or casual sex. Partners of index cases infected through highrisk behaviour (drug use, sexual promiscuity) may also have higher-risk activities, and therefore higher rates of STIs and/or additional sources of exposure other than sex with the index case. Six retrospective-partner studies included index cases who were transfusion recipients; 16, 76, 77, [79] [80] [81] seven studies included index cases infected through various sources, 15, 18, 78, 84, [87] [88] [89] including mainly intravenous drug use; 88, 89 and eight studies included index cases probably infected heterosexually. 19, 62, 63, 66, 67, [70] [71] [72] All fi ve non-partner (ie, simple prospective or retrospective) studies were done in low-income countries among participants after CSE, as clients, 61, 64 FSWs, 73, 75 or men with multiple partners (including sex with FSWs), 21 also with high rates of STIs. 21, 61, 64 Many retrospective partner or discordant couple studies attempted to exclude partners with additional sources of HIV exposure other than sex with the index partner by use of various exclusion criteria. 15, 27, 30, 31, 77, 88, 89, 93 For example, Marincovich and collegues 89 excluded partners who reported parenteral exposure, blood transfusion, tattooing, and multiple partners, whereas Pedraza and colleagues 88 excluded intravenous drug users and promiscuous participants. Infrequent exposure of partners to blood through injections from traditional healers or multiple sexual partners was reported by a few participants in two studies. 62, 63 Based on reported information, we judged that contamination was possible in ten studies because of occasional reports of extramarital sex 15 Because of the high risk associated with CSE, it was generally assumed to be the source of infection, which may not always be the case. 61, 91, 73 Contamination was thought unlikely in two studies, 20, 72 because HIV transmissions within couples were matched by epidemiological linkage. Failure to control for condom use may lead to over-estimation of unprotected sex acts and underestimation of infectivity. Only three studies did not report any attempt to control for condom use or did not provide suffi cient information (webtable 1).
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Figure 2: Crude sex specifi c per-act study estimates For reference, a vertical dotted line is shown at 0·1% because this has previously been a commonly cited value for HIV-1 per-act transmission probability. 49 Pooled data estimates were calculated by random-eff ects meta-analyses. Heterogeneity statistics were calculated on the ln scale. Arrow indicates zero value of estimate and/or lower confi dence limit. See webtable 1 and webappendix for details of individual estimate derivation. 
Review Main meta-analyses
The meta-analysis included 35 crude sex-specifi c (maleto-female, female-to-male, combined) transmission probability estimates (webtable 1, fi gure 2). One publication reported independent estimates from both the prospective discordant and retrospective partner study components, which were both included. 87 Per-act estimates ranged from zero 76, 84, 89 to 8•2%, 61 and showed highly signifi cant heterogeneity (table 1, fi gure 2). The highest (>0·1%) estimates were mostly from low-income countries. The heterogeneity across estimates remained signifi cant even after stratifi cation by sex (table 1) . With further stratifi cation by setting (high-income vs lowincome countries), the heterogeneity across sex-specifi c study estimates was no longer signifi cant for highincome countries only. The pooled combined, female-tomale, and male-to-female high-income country estimates were 0•08% per act (95% CI 0•04-0•16), 0•04% per act (95% CI 0•01-0•14), and 0•08% per act (95% CI 0•06-0•11), respectively. By contrast, the pooled femaleto-male and male-to-female estimates for low-income countries were 0•867% per act (95% CI 0•279-2•601) and 0•193% per act (95% CI 0•086-0•433), respectively. The pooled male-to-female estimate with CSE only was much lower than the female-to-male estimates, indicating the relatively lower Senegalese and recent Kenyan estimates (webtable 1). 73, 75 Interestingly, by excluding estimates after CSE, which were the only estimates from simple prospective and retrospective studies and were exclusively from low-income countries, the pooled maleto-female estimates increased, whereas the female-tomale estimates decreased (table 1). The heterogeneity between low-income country estimates remained.
In univariate meta-regression analyses, a substantial fraction of the variability across all 35 study estimates could be explained by either exposure, setting, STI prevalence, condom use, design, or ANC prevalence (webtable 2). Greater infectivity was associated with CSE, low-income country setting, studies that did not control for condom use, non-partner studies, and higher STI or higher ANC HIV prevalence. The covariates condom and STI (borderline) were no longer signifi cant after excluding estimates with CSE (webtable 2). Among all low-income country estimates, only sex, condom use, and year of publication (negative association) were signifi cantly associated with infectivity; no association was found after removing the estimates with CSE (webtable 2).
The multivariate meta-regression analyses aimed to explain the heterogeneity across the 30 high-income and low-income country estimates without CSE, which were all based on discordant-couple or retrospective partner studies. In models that controlled for sex (p>0·23) and study design (p>0·49), only setting, ANC prevalence or exposure were independently associated with infectivity (p<0•0001) and explained 62-68% of the variability (not shown). In models that included design (p>0·10), sex (p<0·015), setting (p<0·0001), and the interaction between setting and sex (p<0·036), only contamination (p=0·009) or ANC prevalence (p=0·006) remained signifi cant and together explained 83-85% of the variability (not shown). Lower infectivity estimates were associated with the contamination category "no information" compared with the categories "possible" or "unlikely", which were not statistically diff erent (p=0•45). Thus, our fi nal model excluded design and included ANC prevalence (table 2) .
Secondary analyses
Only two studies reported male-to-female estimates for receptive anal intercourse (pooled estimate 1•69% per act [95% CI 0•32-8•91]), 59, 60 and fi ve studies explicitly reported male-to-female estimates for vaginal sex only (pooled estimate 0•076% per act [95% CI 0•052-0•111]). 16, 18, 60, 70, 79 Additional information on these estimates is available from the authors on request.
Six publications reported low-income country estimates stratifi ed by GUD status of HIV-1-susceptible partners, 21, 57, 61, 65, 69 which indicated increased HIV sus cep tibility caused by GUD, or by GUD status of the index case, 19 which indicated increased HIV infectivity. One study was excluded because the confi dence interval could not be derived. 69 The only study 19 among stable couples, reported lower infectivity in the presence of GUD than those reported in the presence of CSE. 21, 57, 61, 65 An additional eight study estimates in the absence of STI were also included. 18 Review estimates, simple explanatory meta-regression analyses were done. We classifi ed the estimates into three categories: study participants without STI; without GUD but potentially other STI; and with GUD and potentially other STI (fi gure 3). The covariate GUD status alone explained 57% of the variability across study estimates.
The meta-regression model with the covariates CSE and GUD status explained a larger fraction of the variability (81%) than GUD status with either covariates setting (77%) or sex (70%; details not shown). Estimates in the presence of GUD were fi ve times larger than estimates in absence of STI, whereas CSE was associated with an 11-times increase in infectivity compared to estimates without CSE (table 3) . Seven studies reported estimates by disease stage of index partners from partner studies (fi gure 4). 17, 20, 56, 58, 60, 78, 81 We only included one 20 of the two studies reporting on the same low income country population. 20 , 56 Wawer and colleagues 20 reported many estimates from diff erent subsamples of discordant couples in which index cases had been infected for diff erent lengths of time. We used the pooled estimate from couples for which index cases had seroconverted for less than 5 months (1•07% per act), which was larger than from couples 6-15 months (0·17% per act) and 16-35 months (0·10% per act) after the index cases had seroconverted (fi gure 4). The study estimate from all couples with prevalent index cases (0•08% per act) was used for the asymptomatic stage. The late-stage estimate used corresponded to 6-15 months before death of index cases (0•49% per act). 20 Per-act estimates were 0•29-1•07%, 0•04-0•093%, and 0•13-5•67% for the early, asymptomatic, and late-stage disease, respectively. Disease stage alone explained 95% of the variability across estimates. After adjusting for disease stages, the addition of the setting covariate was not signifi cant ( Only two studies reported empirical estimates stratifi ed by level of either semen or serum viral load on the same study population (not shown). 19, 20 Partners of index cases who had a median serum viral load of approximately 30 000 HIV RNA copies per mL (range <400-3·1×10⁶ copies per mL <5 months after seroconversion) had a higher infectivity (1•07% per act) than those with a median serum viral load of approximately 2600 copies/mL by 15 months, 20 and even higher than Gray's estimate (0•23% per act) if viral load exceeded 38 500 copies per mL. 19 Wawer and colleagues' 20 estimate from couples for which prevalent index cases were followed up for 0-10 months was higher (0•09% per act at a median of ~10 300 copies per mL), albeit not signifi cantly, than when followed up for more than 30 months (0•04% per act at a median of ~15 000 copies per mL). Gray and colleagues' 19 combined per-act estimates at high (>38 500 serum viral load copies per mL), medium (~1700-12 499 or 12 500-38 499 copies per mL), and low (<1700 copies per mL) viral loads were 0•23%, 0•13% or 0•14%, and 0•01%, respectively. Two studies also reported higher infectivity at higher viral load, but their estimates were not directly comparable because they were derived from theoretical studies based on measurement of HIV-1 viral load by volume of semen. 22, 23 Only two studies reported female-to-male estimates by circumcision status (not shown). 
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Figure 3:
Per-act and pooled estimates for sub-analyses of estimates stratifi ed by genital ulcer disease (GUD) status in HIV-1 susceptible partner † Pooled data estimates were calculated by random-eff ects meta-analyses. Heterogeneity statistics were calculated on the ln scale. Number (N) of participants in the subgroup sample (*total sample size). Arrow indicates zero value of estimate and/or lower confi dence limit. See webappendix for details of individual estimate derivation. †Only one study 19 reported GUD status for the index cases rather than for HIV-susceptible partners. Estimate for Halperin et al 59 was adjusted for anal intercourse, condom use, and history of sexually transmitted infection. Hayes et al's 57 estimate was obtained during episodes of GUD, rather than during follow-up (which included periods with and without GUD episodes). Details for this analysis are available from the authors on request.
Review colleagues' study, 61 
Discussion
Our systematic review and meta-analysis of HIV-1 transmission probabilities per heterosexual act updates and extends the fi ndings of a recent similar review. 49 We confi rmed the earlier observation of substantial heterogeneity in per-act estimates, 49 provided sex-specifi c transmission estimates, and identifi ed additional sources of heterogeneity by exploring interactions between covariates. We also reported the infl uence of key risk factors on infectivity in terms of relative risk (risk ratios), instead of risk diff erence, which is easier to interpret. Heterogeneity across crude study estimates could be mostly explained by CSE as FSWs or clients, setting, sex, and ANC HIV prevalence at the time and location of the study. Although a previous review only found a weak association between sex and infectivity, 49 our results suggested that this may vary by settings. In the subset of estimates without CSE, the pooled female-to-male transmission estimate for high-income countries, adjusted for HIV prevalence, was about half the male-tofemale or combined estimates (RR about 0•5), although the diff erence failed to reach signifi cance. By contrast, the adjusted low-income country female-to-male and male-to-female estimates were very similar (RR about 1•0), and the female-to-male low-income country estimate (RR about 3•3) was signifi cantly larger than the femaleto-male high-income country estimate. The male-tofemale or combined pooled estimates in our sub-analyses in the absence of receptive anal intercourse, GUD, CSE, or for the asymptomatic phase were of similar magnitude (about 0•07% per act) to the male-to-female and combined pooled estimates from high-income countries (about 0•08% per act), which would suggest that they represent the average per-vaginal-sex-act transmission in absence of cofactors, during the asymptomatic phase.
Despite diff erences in some selection criteria and the strategy adopted for the analysis, we confi rmed the fi ndings of previous reviews on the weak infl uence of study quality, 49 and the importance of key risk factors on infectivity. 16, 39, 42, 49, 69, 94 In agreement with studies among homosexual men, 5,95-97 our pooled estimate by receptive anal intercourse supports evidence that it is a more risky practice than receptive vaginal sex. Two studies reporting per-act estimates by circumcision status suggested a three to eight times increase in HIV infection among uncircumcised men overall or in presence of GUD. 21, 61 This is consistent, yet somewhat higher, with the results 
Setting
Low-income High-income Review of two previous meta-analyses, 94, 98 and three recent randomised controlled trials of male circumcision. [99] [100] [101] We found that the presence of GUD and CSE were independently associated with increased infectivity. Our GUD cofactor estimate (RR 5•3) was intermediate between previous study estimates for high-risk groups (10-50 and 50-300 for male-to-female and female-tomale transmission per act, respectively), 57 and those from a meta-analysis of observational studies that reported a 2•8 times (95% CI 2•0-4•0) and 4•4 times (95% CI 2•9-6•6) increase in female and male susceptibility caused by GUD, respectively. 102 Our RRs and estimates from observational studies may be biased because of misclassifi cation, undiagnosed STI, or misreporting of symptoms. Additionally, the intermittent nature of GUD means that it is unlikely to have been present throughout the at-risk period, and percontact cofactor eff ects may therefore be underestimated. 44, 57 Our cofactor estimate predominantly captured the increased HIV susceptibility caused by GUD (only one study reported estimates stratifi ed by GUD status of index cases 19 ). Thus, the increased risk associated with CSE may partly indicate increases in HIV infectivity because highrisk index cases (FSW, clients) would probably have also been infected with GUD or other STIs. Baeten and colleagues' 21 female-to-male study estimate from men with multiple partners (31% monogamous, 57% sex with FSW) was higher than from the subsample of men who only reported sex with their wives (0•63% [0·35-0·91] vs 0•38% [<0·01-69·73] per act, p>0•10).
Sex transmission mode
Interestingly, the early Kenyan 61 and Thai 64 FSW-toclient estimates were substantially larger than the Senegalese and the recent Kenyan client-to-FSW estimates. [73] [74] [75] Although these estimates are probably imprecise because they were based on simple retrospective or cross-sectional study design, the large diff erence (>35 times) could also be caused by other cofactors. STI prevalence may have been lower among Senegalese FSWs because of an early governmental public-health programme, whereby self-identifi ed FSW regularly attended health clinics providing free STI treatment. 103, 104 By contrast, the client studies were done in east Africa (early in the epidemic) and Thailand, where male circumcision prevalence is lower than in west Africa, 105 and at a time when STI and GUD were virtually ubiquitous, FSW were experiencing an explosive HIV epidemic, and index partners were more likely to be in the primary phase of HIV infection. 46, 61, 90, 106 For example, one group reported prevalences of 21% Haemophilus ducreyi, 80% herpes simplex virus 2, and 9% GUD among Thai FSWs. 65, 106 Additionally, Kimani and colleagues 75 suggested that the decline in per-act infectivity observed over calendar time in their study correlated with a decline in STI prevalence among FSWs. Previous individual-based studies showed an association between HIV infectivity and viral load or time since infection.
22,24,28,107-110 Our risk-factor analysis also suggested increased infectivity for index cases in the early and late phase of infection compared with the asymptomatic phase. The diff erence between estimates for the early and late stages was not signifi cant, which may indicate similar infectivity, under-sampling of couples with most recently infected and highly infectious index cases, imprecise defi nition of the duration of the early phase, or lack of statistical power. A recent re-analysis of Wawer and colleagues' data 20 suggested that primary infection and late-stage infection were 26 and seven times higher than asymptomatic infection, respectively, and that the high infectiousness during primary infection lasted approximately 3 months. 111 We initially did not impose any inclusion criteria based on study design because each design has intrinsic biases, even prospective discordant-partner studies, which are seen as the most appropriate design to estimate transmission probabilities. Although discordant-partner studies are likely to reduce recall biases regarding type and frequency of unprotected contacts and HIV cofactors, the reporting of sensitive behaviour is still subject to social desirability biases. Frailty selection, whereby the most vulnerable couples of so-called "high and fast transmitters" rapidly become seroconcordant, 16, 45 may also result in over-sampling of less susceptible partners and/ or less infective index cases who remain uninfected longer and become more likely to be enrolled in such studies. Frailty selection would result in under-estimation of infectivity. Shiboski and colleagues 16, 45 have also suggested that heterogeneity in infectivity was not well shown by the US CDC data 25 and CDC Heterosexual AIDS Transmission Study 27 retrospective-partner studies because the duration of many relationships was too short compared with the time since infection of index cases.
Results from our risk-factor analyses are mainly explanatory. The estimates of the magnitude of the cofactor eff ects may not be very precise because of the small number of studies and covariates that could be explored, the heterogeneity across study estimates, diff erences in risk-factor exposure defi nitions across studies, and because study estimates were based on subgroups of the study sample. Publication biases may also be present because estimates by risk factor may not be reported from studies that did not fi nd a signifi cant association.
The independent positive association between infectivity and setting or ANC HIV prevalence for studies without CSE is diffi cult to interpret, but is unlikely to be caused by study design or analytic methods. As reported previously, 49 study design was only weakly associated with infectivity. Additionally, we converted estimates reported as rates into probabilities (webappendix), which improved comparability across studies. Larger transmission probabilities may lead to higher HIV prevalence in the general population, as estimated in low-income countries. Alternatively, higher HIV prevalence may increase the likelihood of contamination resulting from exposure to additional sources of infection other than sex with the main index Review partner and thus bias estimates upward. Low-income country estimates displayed greater heterogeneity than high-income country estimates. Sex, date of publication, or the covariate condom (confounded with CSE) only explained a signifi cant fraction of the variation across lowincome country estimates (if estimates with CSE were included). This is not entirely surprising given the limited number of studies and that the STI, contamination, and condom-use covariates could only be defi ned broadly, leading to potential misclassifi cation. Thus, the heterogeneity may indicate uncaptured contamination or variation in the prevalence of key risk factors. For example, the larger female-to-male than male-to-female estimates in three discordant-partner studies 19, 62, 70 in low-income countries may indicate contamination, because men are more likely than women to report extramarital sex before or during the study period. 28, 62, 63, 66, 71, 112 Interestingly, in Fideli and colleagues' study, 72 in which transmission events within couples could be epidemiologically linked, femaleto-male transmission was lower than male-to-female transmission. However, their estimates were larger than Wawer and colleagues' study, 20 whereby infections within couples were also confi rmed by epidemiological linkage, which reduces the risk of misclassifi cation, but does not reduce biases caused by misreporting of number of unprotected sex acts or unmeasured risk factors. 113 Because many studies in low-income countries were done within the context of interventions involving an important counselling component, 19, 20, 62, 70, 71 condom use may have been over-reported by study participants, leading to higher infectivity estimates. Nevertheless, reported condom use remained low or even decreased in some studies. 19, 70 Other studies tried to minimise misreporting biases on sexual behaviour by checking for concordance between both members in the couple or using sexual diaries. 19, 66 In Roth and colleagues' study, 63 because men reported more protected sex acts then women, we used the sexual activity reported by women to minimise overestimation of infectivity. Confl icting evidence remains about unmeasured exposure to contaminated equipment or blood transfusion that may have increased low-income country estimates. 7, 8, [10] [11] [12] [114] [115] [116] An early cohort study of registered Senegalese FSWs reported high prevalence of transfusion, scarifi cation, excision, or tattoos, yet HIV prevalence in west Africa and the reported transmission probability estimate for this population are low. 73, 74, 91, 103, 104 We cannot exclude the possibility that our high and heterogeneous low-income country estimates are a result of unmeasured heterogeneity in the prevalence of risk factors. To assert that a 3•5-times diff erence in female-tomale pooled estimates between low-income and highincome countries is solely caused by contamination would imply that approximately 70% of infections are acquired outside the main relationship. Although this seems inconsistent with the relatively low proportion of unlinked infections reported in at least two studies, 20, 72, 112 this remains a subject of debate. [114] [115] [116] [117] Powers and colleagues 49 reported a weak association between region and infectivity, which they assumed was a proxy for viral subtypes. However, they also found greater heterogeneity across estimates from Africa. The reason for the diff erences by setting is likely to be multifactorial. Lack of male circumcision may be more important in low-income countries than in Europe (where circumcision is rare) because of interacting cofactors such as ulcerative STI. 39, [118] [119] [120] [121] Between-settings diff erences may never be completely understood because risk factors such as STI prevalences may have changed since the beginning of the epidemic. 75, 122 Greater heterogeneity in risk factors or median viral loads in low-income countries may exacerbate frailty selection over time. Median plasma viral loads as high as 1·26×10⁶ copies per mL have been observed among acutely infected men in Malawi, and presence of STI was the stronger risk factor associated with high viral load. 42, 121 Thus, intermittent interaction between risk factors may result in very high peaks of infectivity during the incubation period and results in frailty selection at the population level. 42, 121 This possibility may also explain why estimates tended to be lower (albeit not signifi cantly) for couples with prevalent index cases with 31-40 months of follow-up (0•04% per act), compared with 0-10 months (0•09% per act), despite the higher median viral load reported after 30 months. 20 However, unmeasured reduction in prevalence of risk factors resulting from longer exposure to the study or other intervention is also possible.
Heterogeneity across estimates may also be caused by population-level declines in infectivity over calendar time as the fraction of recent seroconverters is expected to decrease in maturing epidemics. 57, 62, 63, 75 Nonoxinol 9 spermicide, which has been associated with increased susceptibility to GUD and HIV infection, 36, 123, 124 was also reported in at least four early African studies. 62, 63, 70, 72 However, in the study by Allen and colleagues, 62 only 12% of women reported the use of nonoxinol 9 without condoms, 6% and 19% reported a history of STI in the past year and past 2 years, respectively, which were similar to estimates reported in the Rakai study. 19 Most studies were done before wide-scale use of antiretroviral therapy and is therefore unlikely to have infl uenced results.
29,32
Conclusions
Our results indicated higher transmission probabilities for low-income than for high-income country studies. The greater heterogeneity of low-income country estimates is itself interesting and may suggest poorer study quality, greater heterogeneity in risk factors, or greater underreporting of high-risk behaviour in these studies. More research is needed to better understand these diff erences, and particularly the low estimates from Rakai. 19, 20 Greater heterogeneity may also be caused by diff erential infectivity of the diff erent viral subtypes, mutation of chemokinereceptor genes, contraception method, genetic, biological, and virological host factors, and interaction with other
Search strategy and selection criteria
These are described in detail in the Methods section.
infectious diseases, 5, [33] [34] [35] [36] [37] [38] [39] [40] [41] 50, [108] [109] [110] [111] 118, [123] [124] [125] Better quantifi cation of per-act infectivity is important to improve understanding of the epidemiology of HIV/AIDS worldwide, to predict the future HIV/AIDS pandemic, and to design appropriate prevention strategies. The methodology of discordantpartner studies could be improved by designing and powering them for carefully planned risk-factor analyses, including epidemiological linkage, by use of data collection methods to reduce social desirability biases, crossvalidating sexual history in couples, and carefully documenting non-sexual potential sources of contamination.
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